Provided by Tiger Fintech (Singapore) Pte. Ltd.

Genmab A/S

22.03
-0.8300-3.63%
Volume:1.57M
Turnover:34.79M
Market Cap:13.57B
PE:12.00
High:22.43
Open:22.39
Low:22.02
Close:22.86
Loading ...

Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)

Business Wire
·
02 May

Genmab A/S Stock Rises Monday, Underperforms Market

Dow Jones
·
29 Apr

Transactions in Connection with Share Buy-back Program

GlobeNewswire
·
28 Apr

Genmab A/S Stock Rises Friday, Outperforms Market

Dow Jones
·
26 Apr

Genmab A/S Stock Rises Tuesday, Outperforms Market

Dow Jones
·
23 Apr

Analysts Have Conflicting Sentiments on These Healthcare Companies: Geron (GERN), Genmab (GMAB) and Elanco Animal Health (ELAN)

TIPRANKS
·
22 Apr

Genmab A/S Stock Falls Wednesday, Outperforms Market

Dow Jones
·
17 Apr

Should Value Investors Buy Genmab (GMAB) Stock?

Zacks
·
16 Apr

Genmab (CPSE:GMAB) Reports US$3 Billion DARZALEX Sales For Q1 2025

Simply Wall St.
·
16 Apr

Genmab Says Darzalex Q1 Global Net Sales Reach $3.24 Billion

MT Newswires Live
·
15 Apr

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
15 Apr

Transactions in Connection with Share Buy-back Program

GlobeNewswire
·
14 Apr

Genmab (GMAB) Gets a Hold from Morgan Stanley

TIPRANKS
·
14 Apr

Genmab A/S Stock Rises Friday, Outperforms Market

Dow Jones
·
12 Apr

Genmab A/S Share Capital Reduction

GlobeNewswire
·
11 Apr

Morgan Stanley Reaffirms Their Hold Rating on Genmab (GMAB)

TIPRANKS
·
10 Apr

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
10 Apr

Genmab Price Target Cut to $37.00/Share From $50.00 by HC Wainwright & Co.

Dow Jones
·
09 Apr

Genmab A/S Stock Falls Monday, Outperforms Market

Dow Jones
·
08 Apr

Morgan Stanley Keeps Their Hold Rating on Genmab (GMAB)

TIPRANKS
·
07 Apr